Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Active, responses due . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM EST
- Posted
- September 30, 2026
- Notice type
- Solicitation
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
- PSC
- AN13: HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- ARPA-H-SOL-26-164
- Notice ID
- 11128fed4f044b68a9185dada11c90d9
Description
The Advanced Research Projects Agency for Health (ARPA-H) posts this solicitation in support of its Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) Program. ARPA-H anticipates multiple Other Transaction Agreement awards will result from this opportunity.
Interested parties are invited to review the attached Solicitation (ARPA-H-SOL-26-164) and associated attachments.
As detailed in Special Notice ARPA-H-SN-26-164, ARPA-H will host an informational webinar on 15 OCT 2026 and a 2-day Proposers’ Day on 6 and 9 NOV 2026 in support of SURPASS.
All questions related to SURPASS should be submitted to SURPASS@ARPA-H.GOV.
Award Overview
Contacts
Contracting Officer
Primary Contact
Documents
Files (3)
Links (3)
- SURPASS Program Pagearpa-h.govPosted
- Submit a Solutionsolutions.arpa-h.govPosted
- Learn more about ARPA-Harpa-h.govPosted
Lifecycle
- 1Version 1SolicitationCurrent
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
- 2Version 2Special Notice
Type changed from Solicitation to Special Notice
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Similar Opportunities
Additional Details
Solicitation Number
ARPA-H-SOL-26-164
Archive Date
Dec 2, 2026
Office Address
Washington, DC, 20005